Type 2 diabetes mellitus (T2DM) and obesity are metabolic disorders characterized by
excess cardiovascular risk. Glucagon-like peptide 1 (GLP1) receptor (GLP1R) agonists …

Echocardiographic evaluation is an essential part of the diagnostic work-up in patients with
known or suspected cardiovascular disease. Transthoracic Doppler echocardiography …

In the past few decades, childhood obesity has become a significant global health issue,
impacting around 107.7 million children and adolescents globally. There is currently minimal …

Obesity remains one of the biggest health problems both in adults and children. Lifestyle
modification, including diet and exercise, continues to be the mainstay of obesity prevention …

Objective: We systematically assessed the efficacy of liraglutide in non-diabetic obese
adults. Methods: Six databases were searched up to July 2021 for randomized controlled …

Abstract Purpose of Review This review aims to explore the role of microvascular
dysfunction in obesity-hypertension, discuss the effects obesity has on renal …

Objective: Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) lower plasma glucose
through effects on insulin and glucagon secretion and by decelerating gastric emptying. GLP …

Aims Coronary microvascular dysfunction (CMD) carries a poor cardiovascular prognosis
and may explain angina in women without obstructive coronary artery disease (CAD) …

Despite the availability of many glucose-lowering drugs, patients with type 2 diabetes
mellitus (T2DM) often do not achieve the desired effect, and cardiovascular complications …

Heart failure with preserved ejection fraction (HFpEF) represents an entity with complex
pathophysiologic pathways, among which coronary microvascular dysfunction (CMD) is …